101
|
Takamochi K, Hayashi T, Hara K, Suzuki K. The PD-L1 expression in surgically resected lung adenocarcinoma: Its correlations with the prognosis, driver oncogene alterations and clinicopathological features. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy445.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
102
|
Moeller A, Qureshi M, Yan S, Dyer M, Suzuki K, Charlot M, Everett P, Litle V, Truong M, Mak K. Pathologic Tumor Response to Neoadjuvant Chemoradiation Predicts Survival in Esophageal Cancer. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
103
|
Wang PN, Leung A, Jang J, Voloshin S, O'Sullivan-Djentuh L, Suzuki K, Ifrah S, Le Gouadec G, Kakizume T, Kitagawa H, Malek K, Miyazaki Y. Safety and efficacy of midostaurin in patients with newly diagnosed FLT3-mutated AML. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy437.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
104
|
Suzuki K, Yuki S, Nakano S, Kawamoto Y, Nakatsumi H, Hatanaka K, Ando T, Furukawa K, Ishiguro A, Ohta T, Eto K, Nakajima J, Nakamura M, Sogabe S, Kato K, Tateyama M, Kato S, Sekiguchi M, Sakata Y, Komatsu Y. HGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of GERCOR index. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy431.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
105
|
Aso M, Sugawara S, Toi Y, Sugisaka J, Ono H, Tsurumi K, Suzuki K, Shimizu H, Domeki Y, Aiba T, Kawana S, Saito R, Terayama K, Kawashima Y, Nakamura A, Yamanda S, Kimura Y, Honda Y. Profiling of immune related adverse events from nivolumab or pembrolizumab monotherapy in advanced non-small cell lung cancer in real world. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy425.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
106
|
Tsutani Y, Miyata Y, Suzuki K, Takamochi K, Tanaka F, Nakayama H, Yamashita Y, Oda M, Tsuboi M, Okada M. Neoadjuvant chemotherapy with bevacizumab followed by surgery for clinical stage II/IIIA non-squamous non-small cell lung cancer: Survival results from a phase II feasibility study (NAVAL). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy290.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
107
|
Kita Y, Suzuki K, Shirakawa Y, Kaga Y, Okumura Y, Kitamura Y, Arakaki K, Mitsuhashi S, Inagaki M, Okuzumi H. An ERP study of inhibitory control in adults with developmental coordination disorder. Int J Psychophysiol 2018. [DOI: 10.1016/j.ijpsycho.2018.07.408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
108
|
Hata K, Suzuki K, Hattori A, Matsunaga T, Takamochi K, Oh S. P2.17-14 How Should Positive Margin for Bronchial Stumps (R1) Be Evaluated in Patients Undergoing Bronchoplasty for Lung Cancer? J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
109
|
Takamochi K, Hosoya M, Mogushi K, Hayashi T, Ito M, Kawaji H, Hayashizaki Y, Suzuki K. Comprehensive analysis for immune profiles of tumor microenvironment in non-small cell lung cancers: Prognostic effect of immunomodulatory molecules. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy290.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
110
|
Suzuki K, Imai H, Kaira K, Anzai M, Tsuda T, Ishizuka T, Kuwako T, Naruse I, Nemoto K, Uchino J, Morozumi N, Ishihara S, Minato K, Hisada T. P1.01-92 A Phase II Study of Afatinib Treatment for Elderly Patients with Previously Untreated Advanced NSCLC Harboring EGFR Mutations. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
111
|
Matsunaga T, Suzuki K, Takamochi K, Oh S. P3.01-71 Results of Extended Resection in T4 Non-Small Cell Lung Cancer. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
112
|
Hirayama S, Fukui M, Hattori A, Takamochi K, Oh S, Suzuki K. P3.16-25 Impact of Diabetes Mellitus on Survival Outcome in Patients with Pathological Stage IA Non-Small Cell Lung Cancer. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
113
|
Suzuki K, Suzuki S, Haruyama Y, Kobashi G, Shiina T, Hirata K. Restless legs syndrome is associated with headache-related disabilities in patients with migraine: a prospective 7-year follow-up study. Eur J Neurol 2018; 26:238-245. [PMID: 30169898 DOI: 10.1111/ene.13796] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2018] [Accepted: 08/28/2018] [Indexed: 11/29/2022]
Abstract
BACKGROUND AND PURPOSE No prospective study has evaluated the impact of restless legs syndrome (RLS) on clinical factors in patients with migraine. We planned a prospective study to assess the impact of RLS comorbid status on clinical factors in patients with migraine. METHODS A total of 101 patients with migraine who were evaluated for RLS twice at 7-year intervals in a university hospital setting were included in this study. The RLS group was defined as positive for RLS at either baseline or follow-up and the non-RLS group was defined as negative for RLS at both baseline and follow-up. The Migraine Disability Assessment (MIDAS) questionnaire, Beck Depression Inventory-II (BDI-II), Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale were administered to all patients. RESULTS The RLS prevalence was 16.8% at baseline and 20.8% at follow-up. Compared with the non-RLS group (n = 27), the RLS group (n = 74) showed a significantly higher rate of smoking and higher MIDAS and BDI-II scores at 7-year follow-up. A significant reduction in MIDAS and BDI-II scores at 7-year follow-up compared with those at baseline was observed in the non-RLS group, but not in the RLS group. The non-RLS group showed a significantly lower MIDAS score at 7-year follow-up than the RLS group after adjusting for confounding variables such as age, gender, smoking status, Epworth Sleepiness Scale and PSQI scores using analysis of covariance. The persistent RLS group (n = 11) (positive for RLS at both baseline and follow-up) showed a significantly higher rate of smoking and increased MIDAS, BDI-II and PSQI scores compared with the non-RLS group (n = 74) at 7-year follow-up. CONCLUSION Our prospective study showed that RLS had a significant impact on headache-related disability in patients with migraine.
Collapse
|
114
|
Takamochi K, Hosoya M, Mogushi K, Hayashi T, Ito M, Kawaji H, Hayashizaki Y, Suzuki K. Comprehensive analysis for immune profiles of tumor microenvironment in lung adenocarcinomas: Prognostic effect of immunomodulatory molecules. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy319.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
115
|
Yoshida S, Suzuki K, Suzuki A, Okada H, Niwa T, Kobayashi R, Murakami N, Ogura S, Itoh Y. Risk factors for the failure of treatment of Pseudomonas aeruginosa bacteremia in critically ill patients. DIE PHARMAZIE 2018; 72:428-432. [PMID: 29441942 DOI: 10.1691/ph.2017.7453] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 09/29/2022]
Abstract
Pseudomonas aeruginosa bacteremia is associated with high morbidity and mortality in critically ill patients. In this study, we assessed risk factors for clinical failure of first definitive therapy for P. aeruginosa bacteremia in critically ill patients. All patients with P. aeruginosa bacteremia who entered the intensive care unit in Gifu University Hospital from January 2006 to December 2015 were retrospectively identified from electronic records. Risk factors associated with clinical failure of the first definitive therapy for P. aeruginosa bacteremia were analyzed by logistic regression analysis. A total of 28 patients were enrolled in the analysis. On multivariate analysis, severe burns (odds ratio [OR] = 70.9, 95% CI 2.9-1720.3; p = 0.009) and SOFA score ≥ 10 (OR = 28.5, 95% CI 1.1-754.3; p = 0.045) were significant factors in the clinical failure of first definitive therapy for P. aeruginosa bacteremia. The clinical success rate of first definitive therapy was significantly reduced in patients with these risk factors compared with those without them (p < 0.001). Severe burns and a SOFA score (≥ 10) were significant risk factors associated with the clinical failure of first definitive therapy for P. aeruginosa bacteremia in critically ill patients. We therefore recommend the use of therapeutic drug monitoring to optimize antibiotic dosing in these critically ill patients.
Collapse
|
116
|
Suzuki K, Iwai H, Yagi M, Fujisawa T, Kanda A, Konishi M, Kobayashi Y, Tomoda K, Yamashita T. Indications for partial parotidectomy using retrograde dissection of the marginal mandibular branch of the facial nerve for benign tumours of the parotid gland. Br J Oral Maxillofac Surg 2018; 56:727-731. [PMID: 30115458 DOI: 10.1016/j.bjoms.2018.08.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2018] [Accepted: 08/03/2018] [Indexed: 10/28/2022]
Abstract
The aims of this study were to evaluate the efficacy of partial parotidectomy using retrograde dissection of the marginal mandibular branch of the facial nerve for benign tumours of the parotid gland and to establish the indications for its use. We examined 106 consecutive patients with previously untreated benign tumours in the lower portion of the parotid gland who were treated by parotidectomy. The first group (anterograde group, n=52) consisted of those who had standard anterograde parotidectomy. The remaining patients, who underwent retrograde parotidectomy, were further divided into two groups: those in whom the upper edge of the tumour was located below the mastoid tip (below mastoid group, n=46) or those in whom it was above the mastoid tip (above mastoid group, n=8). The operating time was significantly shorter in the below mastoid group (141.2, 127.5, and 98.1minutes, respectively) as was intraoperative blood loss (41.1, 53.0, and 24.4ml, respectively), compared with the other two groups. There was a higher incidence of facial nerve dysfunction in the above mastoid group postoperatively (4/8) than in the other two groups. The results suggested that the presence of a tumour of any size located below the mastoid tip is a good indication for parotidectomy using retrograde dissection of the marginal mandibular branch of the facial nerve.
Collapse
|
117
|
Yelton J, Adachi I, Ahn JK, Aihara H, Al Said S, Asner DM, Atmacan H, Aushev T, Ayad R, Babu V, Badhrees I, Bahinipati S, Bakich AM, Bansal V, Beleño C, Berger M, Bhardwaj V, Bhuyan B, Bilka T, Biswal J, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chilikin K, Cho K, Choi SK, Choi Y, Choudhury S, Cinabro D, Cunliffe S, Czank T, Dash N, Di Carlo S, Doležal Z, Dong TV, Drásal Z, Eidelman S, Epifanov D, Fast JE, Fulsom BG, Garg R, Gaur V, Gabyshev N, Garmash A, Gelb M, Giri A, Goldenzweig P, Greenwald D, Guido E, Haba J, Hayasaka K, Hayashii H, Hirose S, Hou WS, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Jacobs WW, Jeon HB, Jia S, Jin Y, Joo KK, Julius T, Kaliyar AB, Kang KH, Karyan G, Kato Y, Kiesling C, Kim DY, Kim JB, Kim KT, Kim SH, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Kroeger R, Krokovny P, Kuhr T, Kumar R, Kuzmin A, Kwon YJ, Lange JS, Lee IS, Lee SC, Li LK, Li YB, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, Masuda M, Matsuda T, Matvienko D, McNeil JT, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moon HK, Mori T, Mussa R, Nakano E, Nakao M, Nanut T, Nath KJ, Natkaniec Z, Niiyama M, Nisar NK, Nishida S, Ono H, Pakhlov P, Pakhlova G, Pal B, Pardi S, Park H, Paul S, Pedlar TK, Pestotnik R, Piilonen LE, Popov V, Ritter M, Russo G, Sahoo D, Sakai Y, Sandilya S, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schwanda C, Seino Y, Senyo K, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Shwartz B, Simon F, Sokolov A, Solovieva E, Starič M, Strube JF, Sumihama M, Sumiyoshi T, Suzuki K, Takizawa M, Tamponi U, Tanida K, Tao Y, Tenchini F, Uchida M, Uglov T, Uno S, Urquijo P, Usov Y, Vahsen SE, Van Hulse C, Varner G, Vorobyev V, Vossen A, Wang B, Wang CH, Wang MZ, Wang P, Wang XL, Watanabe M, Watanuki S, Widmann E, Won E, Ye H, Yuan CZ, Yusa Y, Zakharov S, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V. Observation of an Excited Ω^{-} Baryon. PHYSICAL REVIEW LETTERS 2018; 121:052003. [PMID: 30118260 DOI: 10.1103/physrevlett.121.052003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/23/2018] [Indexed: 06/08/2023]
Abstract
Using data recorded with the Belle detector, we observe a new excited hyperon, an Ω^{*-} candidate decaying into Ξ^{0}K^{-} and Ξ^{-}K_{S}^{0} with a mass of 2012.4±0.7(stat)±0.6(syst) MeV/c^{2} and a width of Γ=6.4_{-2.0}^{+2.5}(stat)±1.6(syst) MeV. The Ω^{*-} is seen primarily in ϒ(1S),ϒ(2S), and ϒ(3S) decays.
Collapse
|
118
|
Sekiguchi H, Yoshimura A, Fukushima T, Suzuki K, Ogiso M, Kawada-Watanabe E, Arashi H, Yamaguchi J, Ogawa H, Hagiwara N. P6242Simple risk score for predicting secondary cardiovascular events in ACS patients undergoing contemporary aggressive lipid-lowering management for dyslipidaemia: a sub-analysis of the HIJ-PROPER study. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
119
|
Yoshikawa M, Iriyama T, Suzuki K, Samejima T, Fujii T, Nagamatsu T, Osuga Y, Fujii T. Reactive oxygen species-mediated activation of apoptosis signal-regulating kinase1 (ASK1) plays a pivotal role in inflammation-induced preterm birth. J Reprod Immunol 2018. [DOI: 10.1016/j.jri.2018.05.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
120
|
Sekiguchi H, Yoshimura A, Fukushima T, Suzuki K, Ogiso M, Kawada-Watanabe E, Arashi H, Yamaguchi J, Ogawa H, Hagiwara N. P2531Comparison of risk factors for cardiovascular outcomes between patients with and without diabetes: results from the HIJ-PROPER Study. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p2531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
121
|
Gandrille S, Borgel D, Ireland H, Lane DA, Simmonds R, Reitsma PH, Mannhalter C, Pabinger I, Saito H, Suzuki K, Formstone C, Cooper DN, Espinosa Y, Sala N, Bernardi F, Aiach M. Protein S Deficiency: A Database of Mutations. Thromb Haemost 2018. [DOI: 10.1055/s-0038-1656138] [Citation(s) in RCA: 38] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
122
|
Shigekiyo T, Uno Y, Kawauchi S, Saito S, Hondo H, Nishioka J, Hayashi T, Suzuki K. Protein S Tokushima: An Abnormal Protein S Found in a Japanese Family with Thrombosis. Thromb Haemost 2018. [DOI: 10.1055/s-0038-1649477] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
SummaryAn abnormal protein S (PS) was found in a Japanese family with a high incidence of thrombosis. The proband is a woman who was born in Tokushima Prefecture. She had superior sagittal sinus thrombosis, thrombophlebitis of the left leg, and thrombosis of the placenta. She had a normal plasma level of free PS antigen but decreased PS activity. Her mother and aunt also had thrombophlebitis of the leg, and together with four other family members also showed a normal level but decreased activity of PS. This suggests that hereditary dysfunction of PS is inherited in this family as an autosomal dominant trait. The proband’s PS appears to have a slightly higher molecular weight than normal PS both in the intact and modified form, suggesting that it has a molecular defect on the carboxyl-terminal side of the thrombin-sensitive site. This abnormal PS with apparently unique characteristics was named PS Tokushima.
Collapse
|
123
|
Suzuki K, Egawa H, Hashimoto S. Comparative Studies of Coagulative and Fibrinolytic Faculties between the Japanese Monkey and the Human. Thromb Haemost 2018. [DOI: 10.1055/s-0038-1649224] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
SummaryIn the present study, the coagulative and the fibrinolytic faculties of the Japanese monkey (Macaca fuscata) were investigated and compared with those of the human.Regarding the coagulative faculty, the plasmic fibrinogen level, prothrombin times, and partial thromboplastin times of the Japanese monkey were similar to those of the human, but the antithrombin level in the monkey was higher than that in the human.Regarding the fibrinolytic faculty, the simian plasminogen level was significantly higher than the human, but the simian, plasma clot and the euglobulin clot lysis times were extremely prolonged, which means that the Japanese monkey has a great fibrinolytic potential, but that it is difficult to activate.In addition, the human and simian reactivities of plasminogen to streptokinase were also investigated and compared.
Collapse
|
124
|
Suzuki K, Wada H, Imai H, Iba T, Thachil J, Toh CH. A re-evaluation of the D-dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: communication from the SSC of the ISTH. J Thromb Haemost 2018; 16:1442-1444. [PMID: 29846034 DOI: 10.1111/jth.14134] [Citation(s) in RCA: 42] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2017] [Indexed: 11/30/2022]
|
125
|
Shimizu Y, Kadone H, Kubota S, Suzuki K, Abe T, Ueno T, Hada Y, Yamazaki M. Heterotopic triggered HAL method for patients with complete quadriplegia or paraplegia due to chronic spinal cord injury. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.1140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|